Zubair Akhtar1, Mohammad Abdul Aleem2,3, Probir Kumar Ghosh2, A K M Monwarul Islam4, Fahmida Chowdhury2, C Raina MacIntyre3, Ole Fröbert5. 1. Programme for Emerging Infections, International Center for Diarrhoeal Diseases, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh. zakhtar@icddrb.org. 2. Programme for Emerging Infections, International Center for Diarrhoeal Diseases, Bangladesh (icddr,b), 68 Shaheed Tajuddin Ahmed Sarani, Mohakhali, Dhaka, 1212, Bangladesh. 3. Faculty of Medicine, University of New South Wales, Sydney, Australia. 4. Department of Cardiology, National Institute of Cardiovascular Diseases Dhaka (NICVD), Dhaka, Bangladesh. 5. Department of Cardiology, Faculty of Health, Örebro University, Örebro, Sweden.
Abstract
BACKGROUND: There is a paucity of data regarding acute phase (in-hospital and 30-day) major adverse cardiac events (MACE) following ST-segment elevation myocardial infarction (STEMI) in Bangladesh. This study aimed to document MACE during the acute phase post-STEMI to provide information. METHODS: We enrolled STEMI patients of the National Institute of Cardiovascular Disease, Dhaka, Bangladesh, from August 2017 to October 2018 and followed up through 30 days post-discharge for MACE, defined as the composite of all-cause death, myocardial infarction, and coronary revascularization. Demographic information, cardiovascular risk factors, and clinical data were registered in a case report form. The Cox proportional hazard model was used for univariate and multivariate analysis to identify potential risk factors for MACE. RESULTS: A total of 601 patients, mean age 51.6 ± 10.3 years, 93% male, were enrolled. The mean duration of hospital stay was 3.8 ± 2.4 days. We found 37 patients (6.2%) to experience an in-hospital event, and 45 (7.5%) events occurred within the 30 days post-discharge. In univariate analysis, a significantly increased risk of developing 30-day MACE was observed in patients with more than 12 years of formal education, diabetes mellitus, or a previous diagnosis of heart failure. In a multivariate analysis, the risk of developing 30-day MACE was increased in patients with heart failure (hazard ratio = 4.65; 95% CI 1.64-13.23). CONCLUSIONS: A high risk of in-hospital and 30-day MACE in patients with STEMI exists in Bangladesh. Additional resources should be allocated providing guideline-recommended treatment for patients with myocardial infarction in Bangladesh.
BACKGROUND: There is a paucity of data regarding acute phase (in-hospital and 30-day) major adverse cardiac events (MACE) following ST-segment elevation myocardial infarction (STEMI) in Bangladesh. This study aimed to document MACE during the acute phase post-STEMI to provide information. METHODS: We enrolled STEMI patients of the National Institute of Cardiovascular Disease, Dhaka, Bangladesh, from August 2017 to October 2018 and followed up through 30 days post-discharge for MACE, defined as the composite of all-cause death, myocardial infarction, and coronary revascularization. Demographic information, cardiovascular risk factors, and clinical data were registered in a case report form. The Cox proportional hazard model was used for univariate and multivariate analysis to identify potential risk factors for MACE. RESULTS: A total of 601 patients, mean age 51.6 ± 10.3 years, 93% male, were enrolled. The mean duration of hospital stay was 3.8 ± 2.4 days. We found 37 patients (6.2%) to experience an in-hospital event, and 45 (7.5%) events occurred within the 30 days post-discharge. In univariate analysis, a significantly increased risk of developing 30-day MACE was observed in patients with more than 12 years of formal education, diabetes mellitus, or a previous diagnosis of heart failure. In a multivariate analysis, the risk of developing 30-day MACE was increased in patients with heart failure (hazard ratio = 4.65; 95% CI 1.64-13.23). CONCLUSIONS: A high risk of in-hospital and 30-day MACE in patients with STEMI exists in Bangladesh. Additional resources should be allocated providing guideline-recommended treatment for patients with myocardial infarction in Bangladesh.
Authors: Nicola S Vos; Giovanni Amoroso; Maarten A Vink; Moniek Maarse; Rob Adams; Jean-Pau R Herrman; Mark S Patterson; Renè J van der Schaaf; Ton Slagboom; Robbert J de Winter Journal: J Invasive Cardiol Date: 2018-10-15 Impact factor: 2.022
Authors: Otavio Berwanger; Eliana Vieira Santucci; Pedro Gabriel Melo de Barros E Silva; Isabella de Andrade Jesuíno; Lucas Petri Damiani; Lilian Mazza Barbosa; Renato Hideo Nakagawa Santos; Ligia Nasi Laranjeira; Flávia de Mattos Egydio; Juliana Aparecida Borges de Oliveira; Frederico Toledo Campo Dall Orto; Pedro Beraldo de Andrade; Igor Ribeiro de Castro Bienert; Carlos Eduardo Bosso; José Armando Mangione; Carisi Anne Polanczyk; Amanda Guerra de Moraes Rego Sousa; Renato Abdala Karam Kalil; Luciano de Moura Santos; Andrei Carvalho Sposito; Rafael Luiz Rech; Antônio Carlos Sobral Sousa; Felipe Baldissera; Bruno Ramos Nascimento; Roberto Rocha Corrêa Veiga Giraldez; Alexandre Biasi Cavalcanti; Sabrina Bernardez Pereira; Luiz Alberto Mattos; Luciana Vidal Armaganijan; Hélio Penna Guimarães; José Eduardo Moraes Rego Sousa; John Hunter Alexander; Christopher Bull Granger; Renato Delascio Lopes Journal: JAMA Date: 2018-04-03 Impact factor: 56.272
Authors: E Boersma; K S Pieper; E W Steyerberg; R G Wilcox; W C Chang; K L Lee; K M Akkerhuis; R A Harrington; J W Deckers; P W Armstrong; A M Lincoff; R M Califf; E J Topol; M L Simoons Journal: Circulation Date: 2000-06-06 Impact factor: 29.690
Authors: Jacqueline Saw; Andrew Starovoytov; Karin Humphries; Tej Sheth; Derek So; Kunal Minhas; Neil Brass; Andrea Lavoie; Helen Bishop; Shahar Lavi; Colin Pearce; Suzanne Renner; Mina Madan; Robert C Welsh; Sohrab Lutchmedial; Ram Vijayaraghavan; Eve Aymong; Bryan Har; Reda Ibrahim; Heather L Gornik; Santhi Ganesh; Christopher Buller; Alexis Matteau; Giuseppe Martucci; Dennis Ko; Giovanni Battista John Mancini Journal: Eur Heart J Date: 2019-04-14 Impact factor: 35.855
Authors: Mohammad Azizul Karim; Abdullah Al Shafi Majumder; Khandaker Qamrul Islam; Muhammad Badrul Alam; Makhan Lal Paul; Mohammad Shafiqul Islam; Kamrun N Chowdhury; Sheikh Mohammed Shariful Islam Journal: BMC Cardiovasc Disord Date: 2015-07-22 Impact factor: 2.298
Authors: Zubair Akhtar; Fahmida Chowdhury; Mohammad Abdul Aleem; Probir Kumar Ghosh; Mahmudur Rahman; Mustafizur Rahman; Mohammad Enayet Hossain; Mariya Kibtiya Sumiya; A K M Monwarul Islam; Mir Jamal Uddin; C Raina MacIntyre; Sara Cajander; Ole Frobert Journal: Open Heart Date: 2021-04